$AVXL News Article - Anavex Life Sciences Reports Recent Data Review by the Independent Data Safety Monitoring Board for its U.S. Phase 2 Clinical Trial of ANAVEX 2-73 in Patients with Rett Syndrome
https://marketwirenews.com/news-releases/anav...18092.html